Srinivas Akkaraju's Net Worth

$3.15 Million

Who is Srinivas Akkaraju?

Srinivas Akkaraju has an estimated net worth of $3.15 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, Principia Biopharma Inc., PHARMOS CORP, EYETECH PHARMACEUTICALS INC, CARGO Therapeutics, Inc., Mineralys Therapeutics, Inc., ZS Pharma, Inc., BARRIER THERAPEUTICS INC, HISTOGENICS CORP, INTERCEPT PHARMACEUTICALS, INC., Graphite Bio, Inc., Aclaris Therapeutics, Inc., CHINOOK THERAPEUTICS, INC., Syros Pharmaceuticals, Inc., Jiya Acquisition Corp., Mirna Therapeutics, Inc., aTYR PHARMA INC, MEI Pharma, Inc., Transcept Pharmaceuticals Inc, Durata Therapeutics, Inc., Versartis, Inc., Scholar Rock Holding Corp, SYNAGEVA BIOPHARMA CORP, ICAGEN INC, Spark Therapeutics, Inc., WORLD HEART CORP, ALIMERA SCIENCES INC, vTv Therapeutics Inc., and ALUMIS INC..

SEC CIK

Srinivas Akkaraju's CIK is 0001253170

Past Insider Trading and Trends

2014 was Srinivas Akkaraju's most active year for acquiring shares with 20 total transactions. Srinivas Akkaraju's most active month to acquire stocks was the month of April. 2023 was Srinivas Akkaraju's most active year for disposing of shares, totalling 18 transactions. Srinivas Akkaraju's most active month to dispose stocks was the month of October. 2014 saw Srinivas Akkaraju paying a total of $2,001,574.80 for 2,215,027 shares, this is the most they've acquired in one year. In 2019 Srinivas Akkaraju cashed out on 38,500 shares for a total of $2,096,119.90, their largest year based on trade value.